Search Results - "Zubair, A.C."

Preliminary Report on the Effect of Mesenchymal Stem Cell (MSC) Infusion in Lung Function on Patients with Chronic Allograft Dysfunction (CLAD) by Keller, C.A, Erasmus, D.B, Alvarez, F.G, Mallea, J.M, Hurst, K.E, David-Robinson, H.A, Zubair, A.C

Get full text

Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD) by Keller, C.A, Russell, A.L, Lefavor, R.C, Desmond, C.M, Hurst, K.E, David-Robinson, H.A, Kontras, D.G, Zubair, A.C

Get full text

Mesenchymal stem cells facilitate neuron recovery after oxygen-glucose deprivation injury by Huang, P, Gebhart, N, Meschia, J.F, Brott, T.G, Zubair, A.C

Get full text

Efficacy and Cost-Benefit Analysis of Plerixafor Plus Filgrastim Based on a Risk Adaptive Approach for Autologous Peripheral Blood Hematopoietic Progenitor Cell Collection by Vishnu, P, Roy, V, Paulsen, A, Zubair, A.C

Get full text

CD34+ Cells From Poor Mobilizers Are Qualitatively Equivalent to CD34+ Cells From Good Mobilizers by Jiang, L, Malik, S, Litzow, M, Gastineau, D, Micallef, I, Roy, V, Solberg, L, Zubair, A.C

Get full text

Association of Surgeon With Surgical Site Infection After Liver Transplantation by Hellinger, W. C., Heckman, M. G., Crook, J. E., Taner, C. B., Willingham, D. L., Diehl, N. N., Zubair, A. C., Shalev, J. A., Nguyen, J. H.

“…Surgical site infection (SSI) after liver transplantation has been associated with increased risk of allograft loss and death. Identification of modifiable…”
Get full text

CD34+ CD38− and CD34+ HLA-DR− cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation by Zubair, A.C., Kao, G., Daley, H., Schott, D., Freedman, A., Ritz, J.

“…Prior studies have demonstrated that relatively immature hematopoietic stem cells, including CD34+ CD38− and CD34+ HLA-DR− subsets, correlate with short-term…”
Get full text

Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants by Zubair, A.C., Rymer, R., Young, J., Keeton, U., Befort, R., Nolot, B., Evans, C., Bleach, T., Torloni, A.

“…Current protocols for myeloma patients require more than one autologous transplant. We performed a retrospective study to determine the cost‐effectiveness of…”
Get full text

CD34+CD38− and CD34+HLA−DR− contents in BMSC grafts correlate with short-term engraftment but have no influence on long-term hematopoietic recovery in patients who received autologous bone marrow transplantation by Zubair, A.C., Kao, G., Ritz, J.

Get full text

Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice by Zubair, A.C., Ali, S.A., Rees, R.C., Goepel, J.R., Goyns, M.H.

“…We have assessed the effectiveness of the metalloproteinase inhibitor BB-94 (batimastat) in reducing the colonization potential of the human Burkitt lymphoma…”
Get full text